This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
apwiita.bsky.social
did:plc:amfketoyptnzxou5l5ihuz3z
‼️Preprint‼️ CD22 CAR Ts are cooked - time to move on to CD72. Adila Izgutdina and fantastic collaborators show CD72 is likely a better second-line antigen than CD22 for CD19-refractory B-ALL/B-NHL. Excited to bring CD72 “nanoCARs” to the clinic @ucsfhealth.bsky.social. https://www.biorxiv.org/content/10.1101/2025.05.09.653155v1
2025-05-16T16:17:25.450Z